Sir Jonathan Symonds CBE
Jon was appointed to the Board as Chair on 1 September 2019.
Jon has extensive international financial, life sciences and governance experience.
Jon served as a Non-Executive Director of Genomics England from October 2013 to October 2025. From April 2014 until February 2020, he was an Independent Non-Executive Director of HSBC Holdings plc where he also served as Chairman of the Group Audit Committee and as Deputy Group Chairman from August 2018. Jon was previously Chairman of HSBC Bank plc, Chief Financial Officer of Novartis AG, Partner and Managing Director of Goldman Sachs, Chief Financial Officer of AstraZeneca plc, and a Partner at KPMG. He was also a Senior Advisor to Chatham House.
Jon is a Fellow of the Institute of Chartered Accountants in England and Wales, an Honorary Fellow of the Oxford School of Pharmacology, and an Honorary Member of the Academy of Medical Sciences.
External appointments:
- Non-Executive Chair, Energy Aspects
- Member, European Round Table for Industry
- Member, Investor & Issuer Forum (I&IF) Steering Committee
